Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
28276 | 210 | 31.2 | 70% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
296 | 3 | BREAST//BREAST CANCER//LYMPHEDEMA | 41323 |
994 | 2 | BREAST CANCER//BREAST CONSERVING THERAPY//BREAST CONSERVING SURGERY | 10470 |
28276 | 1 | TIMING OF RADIOTHERAPY//SURGERY RADIOTHERAPY INTERVAL//CRLC OSCAR LAMBRET | 210 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | TIMING OF RADIOTHERAPY | authKW | 387749 | 2% | 67% | 4 |
2 | SURGERY RADIOTHERAPY INTERVAL | authKW | 290813 | 1% | 100% | 2 |
3 | CRLC OSCAR LAMBRET | address | 261730 | 1% | 60% | 3 |
4 | RADIOTHERAPY TIMING | authKW | 193874 | 1% | 67% | 2 |
5 | 5 FLUOROURACIL CMF | authKW | 145407 | 0% | 100% | 1 |
6 | ABORAT CANC OUTCOME EVALUAT | address | 145407 | 0% | 100% | 1 |
7 | ADJUVANT RADIOTHERAPY RT | authKW | 145407 | 0% | 100% | 1 |
8 | APPOINTMENT DRIES | authKW | 145407 | 0% | 100% | 1 |
9 | AROMATASE INHINITORS | authKW | 145407 | 0% | 100% | 1 |
10 | BIOSTAT COMPUTAT BIOLINT BREAST CANC STUD | address | 145407 | 0% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 5425 | 81% | 0% | 171 |
2 | Radiology, Nuclear Medicine & Medical Imaging | 1526 | 33% | 0% | 70 |
3 | Obstetrics & Gynecology | 36 | 5% | 0% | 10 |
4 | Engineering, Biomedical | 6 | 2% | 0% | 4 |
5 | Biophysics | 5 | 3% | 0% | 6 |
6 | Health Care Sciences & Services | 4 | 1% | 0% | 3 |
7 | Medicine, General & Internal | 4 | 4% | 0% | 8 |
8 | Health Policy & Services | 0 | 0% | 0% | 1 |
9 | Biology | 0 | 1% | 0% | 2 |
10 | Rehabilitation | 0 | 0% | 0% | 1 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CRLC OSCAR LAMBRET | 261730 | 1% | 60% | 3 |
2 | ABORAT CANC OUTCOME EVALUAT | 145407 | 0% | 100% | 1 |
3 | BIOSTAT COMPUTAT BIOLINT BREAST CANC STUD | 145407 | 0% | 100% | 1 |
4 | HPSERV ONCOL RADIOTHER IE | 145407 | 0% | 100% | 1 |
5 | INSERM EMI0227 | 145407 | 0% | 100% | 1 |
6 | INTELLIGENT IMPROVEMENT CONSULTANTS I2C | 145407 | 0% | 100% | 1 |
7 | JE 2488 | 145407 | 0% | 100% | 1 |
8 | MED RC08 MED ONCOL | 145407 | 0% | 100% | 1 |
9 | MED RC08 SURG | 145407 | 0% | 100% | 1 |
10 | ONCOLCANC EPIDEMIOL GRP EPIDEMIOL BIO | 145407 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 10343 | 17% | 0% | 35 |
2 | CLINICAL ONCOLOGY | 6898 | 4% | 1% | 9 |
3 | RADIOTHERAPY AND ONCOLOGY | 2950 | 5% | 0% | 11 |
4 | STRAHLENTHERAPIE UND ONKOLOGIE | 2119 | 3% | 0% | 6 |
5 | AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 1760 | 3% | 0% | 7 |
6 | BREAST CANCER RESEARCH AND TREATMENT | 1617 | 4% | 0% | 9 |
7 | BREAST JOURNAL | 1246 | 1% | 0% | 3 |
8 | BULLETIN DU CANCER | 1236 | 3% | 0% | 6 |
9 | TUMORI | 1113 | 3% | 0% | 6 |
10 | JOURNAL OF CLINICAL ONCOLOGY | 1074 | 5% | 0% | 11 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | GUPTA, S , KING, WD , KORZENIOWSKI, M , WALLACE, DL , MACKILLOP, WJ , (2016) THE EFFECT OF WAITING TIMES FOR POSTOPERATIVE RADIOTHERAPY ON OUTCOMES FOR WOMEN RECEIVING PARTIAL MASTECTOMY FOR BREAST CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS.CLINICAL ONCOLOGY. VOL. 28. ISSUE 12. P. 739 -749 | 34 | 65% | 0 |
2 | CHEN, Z , KING, W , PEARCEY, R , KERBA, M , MACKILLOP, WJ , (2008) THE RELATIONSHIP BETWEEN WAITING TIME FOR RADIOTHERAPY AND CLINICAL OUTCOMES: A SYSTEMATIC REVIEW OF THE LITERATURE.RADIOTHERAPY AND ONCOLOGY. VOL. 87. ISSUE 1. P. 3-16 | 33 | 49% | 106 |
3 | CAPONIO, R , CILIBERTI, MP , GRAZIANO, G , NECCHIA, R , SCOGNAMILLO, G , PASCALI, A , BONADUCE, S , MILELLA, A , MATICHECCHIA, G , CRISTOFARO, C , ET AL (2016) WAITING TIME FOR RADIATION THERAPY AFTER BREAST-CONSERVING SURGERY IN EARLY BREAST CANCER: A RETROSPECTIVE ANALYSIS OF LOCAL RELAPSE AND DISTANT METASTASES IN 615 PATIENTS.EUROPEAN JOURNAL OF MEDICAL RESEARCH. VOL. 21. ISSUE . P. - | 25 | 60% | 0 |
4 | BOWDEN, SJ , FERNANDO, IN , BURTON, A , (2006) DELAYING RADIOTHERAPY FOR THE DELIVERY OF ADJUVANT CHEMOTHERAPY IN THE COMBINED MODALITY TREATMENT OF EARLY BREAST CANCER: IS IT DISADVANTAGEOUS AND COULD COMBINED TREATMENT BE THE ANSWER?.CLINICAL ONCOLOGY. VOL. 18. ISSUE 3. P. 247-256 | 29 | 59% | 9 |
5 | HICKEY, BE , FRANCIS, DP , LEHMAN, M , (2013) SEQUENCING OF CHEMOTHERAPY AND RADIOTHERAPY FOR EARLY BREAST CANCER.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 4. P. - | 26 | 54% | 1 |
6 | TSOUTSOU, PG , BELKACEMI, Y , GLIGOROV, J , KUTEN, A , BOUSSEN, H , BESE, N , KOUKOURAKIS, MI , (2010) OPTIMAL SEQUENCE OF IMPLIED MODALITIES IN THE ADJUVANT SETTING OF BREAST CANCER TREATMENT: AN UPDATE ON ISSUES TO CONSIDER.ONCOLOGIST. VOL. 15. ISSUE 11. P. 1169 -1178 | 35 | 40% | 4 |
7 | TSOUTSOU, PG , KOUKOURAKIS, MI , AZRIA, D , BELKACEMI, Y , (2009) OPTIMAL TIMING FOR ADJUVANT RADIATION THERAPY IN BREAST CANCER A COMPREHENSIVE REVIEW AND PERSPECTIVES.CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. VOL. 71. ISSUE 2. P. 102-116 | 37 | 35% | 19 |
8 | SCOCCIANTI, S , AGRESTI, B , SIMONTACCHI, G , DETTI, B , CIPRESSI, S , IANNALFI, A , MARRAZZO, L , MANGONI, M , PAIAR, F , LIVI, L , ET AL (2012) FROM A WAITING LIST TO A PRIORITY LIST: A COMPUTERIZED MODEL FOR AN EASY-TO-MANAGE AND AUTOMATICALLY UPDATED PRIORITY LIST IN THE BOOKING OF PATIENTS WAITING FOR RADIOTHERAPY.TUMORI. VOL. 98. ISSUE 6. P. 728-735 | 15 | 75% | 0 |
9 | LIVI, L , SAIEVA, C , BORGHESI, S , PAOLETTI, L , MEATTINI, I , RAMPINI, A , PETRUCCI, A , SCOCCIANTI, S , PAIAR, F , CATALIOTTI, L , ET AL (2008) CONCURRENT CYCLOPHOSPHAMIDE, METHOTREXATE, AND 5-FLUOROURACIL CHEMOTHERAPY AND RADIOTHERAPY FOR EARLY BREAST CARCINOMA.INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. VOL. 71. ISSUE 3. P. 705-709 | 17 | 68% | 9 |
10 | KARLSSON, P , COLE, BF , PRICE, KN , GELBER, RD , COATES, AS , GOLDHIRSCH, A , CASTIGLIONE, M , COLLEONI, M , GRUBER, G , (2016) TIMING OF RADIATION THERAPY AND CHEMOTHERAPY AFTER BREAST-CONSERVING SURGERY FOR NODE-POSITIVE BREAST CANCER: LONG-TERM RESULTS FROM INTERNATIONAL BREAST CANCER STUDY GROUP TRIALS VI AND VII.INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. VOL. 96. ISSUE 2. P. 273 -279 | 12 | 80% | 0 |
Classes with closest relation at Level 1 |